Author Title [ Type(Desc)] Year
Filters: Author is Ahmadi, Majid  [Clear All Filters]
Journal Article
Ahmadi, M., Yousefi, M., Abbaspour-Aghdam, S., Dolati, S., Aghebati-Maleki, L., Eghbal-Fard, S., Khabbazi, A., Rostamzadeh, D., Alipour, S., Shabani, M., et al. (2018). Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.J Cell Physiol.
Eghbal-Fard, S., Yousefi, M., Heydarlou, H., Ahmadi, M., Taghavi, S., Movasaghpour, A., Jadidi-Niaragh, F., Yousefi, B., Dolati, S., Hojjat-Farsangi, M., et al. (2018). The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia.J Cell Physiol.
Gharibi, T., Ahmadi, M., Seyfizadeh, N., Jadidi-Niaragh, F., and Yousefi, M. (2015). Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.Cell Immunol293, 113-121.
Jafarzadeh, S., Ahmadi, M., Dolati, S., Aghebati-Maleki, L., Eghbal-Fard, S., Kamrani, A., Behrad, B., Roshangar, L., Jadidi-Niaragh, F., Yousefi, B., et al. (2018). Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.J Cell Biochem.
Rostamzadeh, D., Yousefi, M., Haghshenas, M.Reza, Ahmadi, M., Dolati, S., and Babaloo, Z. (2019). mTOR Signaling pathway as a master regulator of memory CD8 T-cells, Th17, and NK cells development and their functional properties.J Cell Physiol.
Hajialilo, M., Dolati, S., Abdolmohammadi-Vahid, S., Ahmadi, M., Kamrani, A., Eghbal-Fard, S., Ghassembaglou, A., Valizadeh, A., Shenas, M.Hossein Mu, Aghebati-Maleki, L., et al. (2019). Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function.J Cell Biochem.
Ahmadi, M., Ghaebi, M., Abdolmohammadi-Vahid, S., Abbaspour-Aghdam, S., Hamdi, K., Abdollahi-Fard, S., Danaii, S., Mosapour, P., Koushaeian, L., Dolati, S., et al. (2018). NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.J Cell Physiol.
Kamrani, A., Alipourfard, I., Ahmadi-Khiavi, H., Yousefi, M., Rostamzadeh, D., Izadi, M., and Ahmadi, M. (2019). The role of epigenetic changes in preeclampsia.Biofactors.
Koushaeian, L., Ghorbani, F., Ahmadi, M., Eghbal-Fard, S., Zamani, M., Danaii, S., Yousefi, B., Jadidi-Niaragh, F., Hamdi, K., and Yousefi, M. (2019). The role of IL-10-producing B cells in Repeated Implantation Failure patients with cellular immune abnormalities.Immunol Lett.
Ahmadi, M., Abdolmohamadi-Vahid, S., Ghaebi, M., Dolati, S., Abbaspour-Aghdam, S., Danaii, S., Berjis, K., Madadi-Javid, R., Nouri, Z., Siahmansouri, H., et al. (2019). Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.Int Immunopharmacol74, 105730.
Ghaebi, M., Abdolmohammadi-Vahid, S., Ahmadi, M., Eghbal-Fard, S., Dolati, S., Nouri, M., Talebi, M., Hamdi, K., Marofi, F., Aghebati-Maleki, L., et al. (2018). T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure.J Reprod Immunol131, 21-29.